Published in J Virol on November 01, 1997
Role of ICP0 in the strategy of conquest of the host cell by herpes simplex virus 1. J Virol (2004) 2.69
Nuclear IFI16 induction of IRF-3 signaling during herpesviral infection and degradation of IFI16 by the viral ICP0 protein. Proc Natl Acad Sci U S A (2012) 2.14
Herpes simplex virus type 1 and bovine herpesvirus 1 latency. Clin Microbiol Rev (2003) 1.62
A viral ubiquitin ligase has substrate preferential SUMO targeted ubiquitin ligase activity that counteracts intrinsic antiviral defence. PLoS Pathog (2011) 1.47
Herpes simplex virus type 1 latency-associated transcripts suppress viral replication and reduce immediate-early gene mRNA levels in a neuronal cell line. J Virol (1998) 1.40
The two functions of herpes simplex virus 1 ICP0, inhibition of silencing by the CoREST/REST/HDAC complex and degradation of PML, are executed in tandem. J Virol (2008) 1.40
Assembly of an active translation initiation factor complex by a viral protein. Genes Dev (2006) 1.32
Herpes simplex virus immediate-early ICP0 protein inhibits Toll-like receptor 2-dependent inflammatory responses and NF-kappaB signaling. J Virol (2010) 1.23
The bovine herpesvirus 1 immediate-early protein (bICP0) associates with histone deacetylase 1 to activate transcription. J Virol (2001) 1.14
The predicted metal-binding region of the arterivirus helicase protein is involved in subgenomic mRNA synthesis, genome replication, and virion biogenesis. J Virol (2000) 1.09
Activities of ICP0 involved in the reversal of silencing of quiescent herpes simplex virus 1. J Virol (2011) 1.05
The co-chaperone BAG3 regulates Herpes Simplex Virus replication. Proc Natl Acad Sci U S A (2008) 1.01
Regulation of Innate Immune Responses by Bovine Herpesvirus 1 and Infected Cell Protein 0 (bICP0). Viruses (2009) 0.99
HSV-1 degrades, stabilizes, requires, or is stung by STING depending on ICP0, the US3 protein kinase, and cell derivation. Proc Natl Acad Sci U S A (2014) 0.98
Interactions of the Antiviral Factor Interferon Gamma-Inducible Protein 16 (IFI16) Mediate Immune Signaling and Herpes Simplex Virus-1 Immunosuppression. Mol Cell Proteomics (2015) 0.98
Characterization of the trans-activation properties of equine herpesvirus 1 EICP0 protein. J Virol (2000) 0.97
HSV-1 ICP0: paving the way for viral replication. Future Virol (2011) 0.94
Herpes simplex virus 1 mutant in which the ICP0 HUL-1 E3 ubiquitin ligase site is disrupted stabilizes cdc34 but degrades D-type cyclins and exhibits diminished neurotoxicity. J Virol (2003) 0.93
Herpes simplex virus type 1 ICP0 phosphorylation mutants impair the E3 ubiquitin ligase activity of ICP0 in a cell type-dependent manner. J Virol (2008) 0.90
During its nuclear phase the multifunctional regulatory protein ICP0 undergoes proteolytic cleavage characteristic of polyproteins. Proc Natl Acad Sci U S A (2009) 0.90
Herpes simplex virus 1 precludes replenishment of the short-lived receptor of tumor necrosis factor alpha by virion host shutoff-dependent degradation of its mRNA. J Virol (2006) 0.90
Herpes simplex virus type 1 entry is inhibited by the cobalt chelate complex CTC-96. J Virol (2001) 0.89
UL54-null pseudorabies virus is attenuated in mice but productively infects cells in culture. J Virol (2006) 0.88
Herpes simplex virus 1 infection activates poly(ADP-ribose) polymerase and triggers the degradation of poly(ADP-ribose) glycohydrolase. J Virol (2012) 0.86
The infected cell protein 0 encoded by bovine herpesvirus 1 (bICP0) associates with interferon regulatory factor 7 and consequently inhibits beta interferon promoter activity. J Virol (2009) 0.85
A proteomic perspective of inbuilt viral protein regulation: pUL46 tegument protein is targeted for degradation by ICP0 during herpes simplex virus type 1 infection. Mol Cell Proteomics (2013) 0.84
Interaction of herpes simplex virus ICP0 with ND10 bodies: a sequential process of adhesion, fusion, and retention. J Virol (2013) 0.83
Complementation of a herpes simplex virus ICP0 null mutant by varicella-zoster virus ORF61p. J Virol (2009) 0.83
The NH2 terminus of the herpes simplex virus type 1 regulatory protein ICP0 contains a promoter-specific transcription activation domain. J Virol (1998) 0.83
Bcl-2 blocks accretion or depletion of stored calcium but has no effect on the redistribution of IP3 receptor I mediated by glycoprotein E of herpes simplex virus 1. J Virol (2007) 0.82
Depletion of intracellular zinc inhibits the ubiquitin ligase activity of viral regulatory protein ICP0 and restricts herpes simplex virus 1 replication in cell culture. J Virol (2012) 0.81
The zinc RING finger of bovine herpesvirus 1-encoded bICP0 protein is crucial for viral replication and virulence. J Virol (2008) 0.81
Identification of TRIM27 as a novel degradation target of herpes simplex virus 1 ICP0. J Virol (2014) 0.80
Infected cell protein 0 functional domains and their coordination in herpes simplex virus replication. World J Virol (2016) 0.79
Cytoplasmic localized infected cell protein 0 (bICP0) encoded by bovine herpesvirus 1 inhibits β interferon promoter activity and reduces IRF3 (interferon response factor 3) protein levels. Virus Res (2011) 0.79
The stability of herpes simplex virus 1 ICP0 early after infection is defined by the RING finger and the UL13 protein kinase. J Virol (2014) 0.78
Human antiviral protein IFIX suppresses viral gene expression during HSV-1 infection and is counteracted by virus-induced proteasomal degradation. Mol Cell Proteomics (2017) 0.78
Role of ND10 nuclear bodies in the chromatin repression of HSV-1. Virol J (2016) 0.78
Advances in targeting nucleocapsid-nucleic acid interactions in HIV-1 therapy. Virus Res (2014) 0.77
A Tale of Two PMLs: Elements Regulating a Differential Substrate Recognition by the ICP0 E3 Ubiquitin Ligase of Herpes Simplex Virus 1. J Virol (2016) 0.75
Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (1970) 1528.65
Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci U S A (1979) 365.71
Selective extraction of polyoma DNA from infected mouse cell cultures. J Mol Biol (1967) 106.91
Regulation of herpesvirus macromolecular synthesis. I. Cascade regulation of the synthesis of three groups of viral proteins. J Virol (1974) 26.25
DNA-mediated transfer of the adenine phosphoribosyltransferase locus into mammalian cells. Proc Natl Acad Sci U S A (1979) 21.22
Regulation of herpesvirus macromolecular synthesis: sequential transition of polypeptide synthesis requires functional viral polypeptides. Proc Natl Acad Sci U S A (1975) 11.52
Analysis of mutation in human cells by using an Epstein-Barr virus shuttle system. Mol Cell Biol (1987) 11.36
Control of herpes simplex virus type 1 mRNA synthesis in cells infected with wild-type virus or the temperature-sensitive mutant tsK. J Virol (1979) 11.34
RNA complementary to a herpesvirus alpha gene mRNA is prominent in latently infected neurons. Science (1987) 11.14
Fine-structure mapping and functional analysis of temperature-sensitive mutants in the gene encoding the herpes simplex virus type 1 immediate early protein VP175. J Virol (1980) 9.30
A herpes simplex virus type 1 function continuously required for early and late virus RNA synthesis. Nature (1980) 8.47
Regulation of herpesvirus macromolecular synthesis. V. Properties of alpha polypeptides made in HSV-1 and HSV-2 infected cells. Virology (1977) 8.24
Isolation and characterization of deletion mutants of herpes simplex virus type 1 in the gene encoding immediate-early regulatory protein ICP4. J Virol (1985) 8.12
Temporal regulation of herpes simplex virus type 1 transcription: location of transcripts on the viral genome. Cell (1977) 7.60
Evidence for a direct role for both the 175,000- and 110,000-molecular-weight immediate-early proteins of herpes simplex virus in the transactivation of delayed-early promoters. J Virol (1985) 7.39
Trans activation of transcription by herpes virus products: requirement for two HSV-1 immediate-early polypeptides for maximum activity. EMBO J (1984) 7.33
Isolation and characterization of a herpes simplex virus type 1 mutant containing a deletion within the gene encoding the immediate early polypeptide Vmw110. J Gen Virol (1986) 6.74
Herpes simplex virus type 1 ICP27 is an essential regulatory protein. J Virol (1985) 6.67
Deletion mutants in the gene encoding the herpes simplex virus type 1 immediate-early protein ICP0 exhibit impaired growth in cell culture. J Virol (1987) 5.71
Herpes simplex virus phosphoproteins. I. Phosphate cycles on and off some viral polypeptides and can alter their affinity for DNA. J Virol (1980) 5.69
Three trans-acting regulatory proteins of herpes simplex virus modulate immediate-early gene expression in a pathway involving positive and negative feedback regulation. J Virol (1985) 5.63
Identification of immediate early genes from herpes simplex virus that transactivate the virus thymidine kinase gene. Proc Natl Acad Sci U S A (1985) 5.40
Optimized use of the firefly luciferase assay as a reporter gene in mammalian cell lines. Biotechniques (1990) 5.02
HSV-1 IE protein Vmw110 causes redistribution of PML. EMBO J (1994) 4.61
A novel cysteine-rich sequence motif. Cell (1991) 4.39
Characterization of herpes simplex virus 1 alpha proteins 0, 4, and 27 with monoclonal antibodies. J Virol (1984) 4.37
Modification of discrete nuclear domains induced by herpes simplex virus type 1 immediate early gene 1 product (ICP0). J Gen Virol (1993) 4.32
The nuclear location of PML, a cellular member of the C3HC4 zinc-binding domain protein family, is rearranged during herpes simplex virus infection by the C3HC4 viral protein ICP0. J Gen Virol (1994) 4.32
Herpes simplex virus type 1 ICP27 deletion mutants exhibit altered patterns of transcription and are DNA deficient. J Virol (1989) 4.18
Viral DNA synthesis is required for the efficient expression of specific herpes simplex virus type 1 mRNA species. Virology (1980) 4.05
Identification of a novel nuclear domain. J Cell Biol (1991) 3.91
Herpes simplex virus type 1 ICP0 plays a critical role in the de novo synthesis of infectious virus following transfection of viral DNA. J Virol (1989) 3.63
Quantification of transcripts from the ICP4 and thymidine kinase genes in mouse ganglia latently infected with herpes simplex virus. J Virol (1995) 3.18
The RING finger. A novel protein sequence motif related to the zinc finger. Ann N Y Acad Sci (1993) 3.17
The products of herpes simplex virus type 1 (HSV-1) immediate early genes 1, 2 and 3 can activate HSV-1 gene expression in trans. J Gen Virol (1986) 3.15
Herpes simplex virus type 1 ICP0 regulates expression of immediate-early, early, and late genes in productively infected cells. J Virol (1992) 3.10
Gene-specific transactivation by herpes simplex virus type 1 alpha protein ICP27. J Virol (1988) 3.08
Construction and characterization of herpes simplex virus type 1 mutants with defined lesions in immediate early gene 1. J Gen Virol (1989) 2.97
The solution structure of the RING finger domain from the acute promyelocytic leukaemia proto-oncoprotein PML. EMBO J (1995) 2.93
Interaction of herpes simplex virus 1 alpha regulatory protein ICP0 with elongation factor 1delta: ICP0 affects translational machinery. J Virol (1997) 2.87
An activity specified by the osteosarcoma line U2OS can substitute functionally for ICP0, a major regulatory protein of herpes simplex virus type 1. J Virol (1995) 2.82
Herpes simplex virus type 1 immediate-early protein Vmw110 reactivates latent herpes simplex virus type 2 in an in vitro latency system. J Virol (1989) 2.76
Co-ordinate regulation of herpes simplex virus gene expression is mediated by the functional interaction of two immediate early gene products. J Mol Biol (1986) 2.65
A detailed mutational analysis of Vmw110, a trans-acting transcriptional activator encoded by herpes simplex virus type 1. EMBO J (1987) 2.56
Structure of the C3HC4 domain by 1H-nuclear magnetic resonance spectroscopy. A new structural class of zinc-finger. J Mol Biol (1994) 2.47
Analysis of the functional domains of herpes simplex virus type 1 immediate-early polypeptide Vmw110. J Mol Biol (1988) 2.46
A cellular function can enhance gene expression and plating efficiency of a mutant defective in the gene for ICP0, a transactivating protein of herpes simplex virus type 1. J Virol (1991) 2.25
Construction in vitro and rescue of a thymidine kinase-deficient deletion mutation of herpes simplex virus. Nature (1980) 2.14
RNA polymerase II is aberrantly phosphorylated and localized to viral replication compartments following herpes simplex virus infection. J Virol (1994) 2.12
Restricted transcription of the herpes simplex virus genome occurring early after infection and in the presence of metabolic inhibitors. Virology (1975) 2.09
The herpes simplex virus immediate-early protein ICP0 affects transcription from the viral genome and infected-cell survival in the absence of ICP4 and ICP27. J Virol (1997) 2.06
Reactivation of latent herpes simplex virus by adenovirus recombinants encoding mutant IE-0 gene products. J Virol (1990) 2.03
Herpes simplex virus immediate-early promoters are responsive to virus and cell trans-acting factors. J Virol (1987) 1.96
Herpes simplex viruses with mutations in the gene encoding ICP0 are defective in gene expression. J Virol (1992) 1.92
The latency-associated transcripts of herpes simplex virus: RNA in search of function. Virology (1992) 1.89
Identification of a promoter mapping within the reiterated sequences that flank the herpes simplex virus type 1 UL region. J Virol (1993) 1.77
Properties of herpesvirus-induced "immediate early" polypeptides. Virology (1980) 1.75
A novel arrangement of zinc-binding residues and secondary structure in the C3HC4 motif of an alpha herpes virus protein family. J Mol Biol (1993) 1.68
Immediate-early RNA 2.9 and early RNA 2.6 of bovine herpesvirus 1 are 3' coterminal and encode a putative zinc finger transactivator protein. J Virol (1992) 1.66
Transcriptional repressor ZF5 identifies a new conserved domain in zinc finger proteins. Nucleic Acids Res (1993) 1.65
Type 1 plasminogen activator inhibitor gene: functional analysis and glucocorticoid regulation of its promoter. Proc Natl Acad Sci U S A (1988) 1.64
Herpes simplex ICP27 mutant viruses exhibit reduced expression of specific DNA replication genes. J Virol (1996) 1.61
Characterization of a potent varicella-zoster virus-encoded trans-repressor. J Virol (1991) 1.57
Herpes simplex virus type 1 prereplicative sites are a heterogeneous population: only a subset are likely to be precursors to replication compartments. J Virol (1997) 1.56
Functional interactions between herpes simplex virus immediate-early proteins during infection: gene expression as a consequence of ICP27 and different domains of ICP4. J Virol (1995) 1.48
Varicella-zoster virus (VZV) open reading frame 61 protein transactivates VZV gene promoters and enhances the infectivity of VZV DNA. J Virol (1993) 1.45
Physical and functional interactions between herpes simplex virus immediate-early proteins ICP4 and ICP27. J Virol (1997) 1.38
Mutational analysis of the sequence encoding ICP0 from herpes simplex virus type 1. Virology (1991) 1.31
Isolation and characterization of a functional cDNA encoding ICP0 from herpes simplex virus type 1. J Virol (1991) 1.06
Mutational analysis of ICP0R, a transrepressor protein created by alternative splicing of the ICP0 gene of herpes simplex virus type 1. J Virol (1996) 0.95
Relationship of the expression of the S20 and L34 ribosomal proteins to polyamine biosynthesis in Escherichia coli. Int J Biochem Cell Biol (1995) 0.94
A poxvirus protein with a RING finger motif binds zinc and localizes in virus factories. J Virol (1994) 0.94
Repression of the alpha0 gene by ICP4 during a productive herpes simplex virus infection. J Virol (1996) 0.92
Differential dependence of herpes simplex virus immediate-early gene expression on de novo-infected cell protein synthesis. J Virol (1991) 0.92
DNA-mediated transfer of the adenine phosphoribosyltransferase locus into mammalian cells. Proc Natl Acad Sci U S A (1979) 21.22
Transformation of mammalian cells with genes from procaryotes and eucaryotes. Cell (1979) 21.15
Biochemical transfer of single-copy eucaryotic genes using total cellular DNA as donor. Cell (1978) 19.44
Transfer of purified herpes virus thymidine kinase gene to cultured mouse cells. Cell (1977) 18.95
The transfer and stable integration of the HSV thymidine kinase gene into mouse cells. Cell (1978) 6.38
Identification of immediate early genes from herpes simplex virus that transactivate the virus thymidine kinase gene. Proc Natl Acad Sci U S A (1985) 5.40
Altering genotype and phenotype by DNA-mediated gene transfer. Science (1980) 3.82
Introduction and expression of a rabbit beta-globin gene in mouse fibroblasts. Proc Natl Acad Sci U S A (1979) 3.53
Transformation of mammalian cells with an amplifiable dominant-acting gene. Proc Natl Acad Sci U S A (1980) 3.39
Relationship between post-transcriptional adenylation of herpes virus RNA and messenger RNA abundance. Proc Natl Acad Sci U S A (1973) 2.83
Herpes simplex virus type 1 immediate-early protein Vmw110 reactivates latent herpes simplex virus type 2 in an in vitro latency system. J Virol (1989) 2.76
Isolation of transforming DNA: cloning the hamster aprt gene. Cell (1980) 2.73
Degradation of cellular mRNA during infection by herpes simplex virus. Proc Natl Acad Sci U S A (1977) 2.72
Cervical papillomaviruses segregate within morphologically distinct precancerous lesions. J Virol (1985) 2.70
Co-ordinate regulation of herpes simplex virus gene expression is mediated by the functional interaction of two immediate early gene products. J Mol Biol (1986) 2.65
Macrophages and viral immunity. Semin Hematol (1970) 2.53
Requirement of protein synthesis for the degradation of host mRNA in Friend erythroleukemia cells infected wtih herpes simplex virus type 1. J Virol (1978) 2.51
Restriction fragment length polymorphism of polymerase chain reaction products from vaccine and wild-type varicella-zoster virus isolates. J Virol (1992) 2.37
Transcription: role in the initiation and replication of DNA synthesis in Escherichia coli and phiX174. Biochim Biophys Acta (1971) 2.35
Portability issues for a structured clinical vocabulary: mapping from Yale to the Columbia medical entities dictionary. J Am Med Inform Assoc (1996) 2.24
Pre-mRNA splicing and the nuclear matrix. Mol Cell Biol (1987) 2.22
Reactivation of latent herpes simplex virus by adenovirus recombinants encoding mutant IE-0 gene products. J Virol (1990) 2.03
Herpes simplex virus immediate-early promoters are responsive to virus and cell trans-acting factors. J Virol (1987) 1.96
Herpes simplex viruses with mutations in the gene encoding ICP0 are defective in gene expression. J Virol (1992) 1.92
"Transactivation" control signals in the promoter of the herpesvirus thymidine kinase gene. Proc Natl Acad Sci U S A (1985) 1.87
Properties of RNA transcriptase in reovirus subviral particles. Proc Natl Acad Sci U S A (1970) 1.82
Identification of a promoter mapping within the reiterated sequences that flank the herpes simplex virus type 1 UL region. J Virol (1993) 1.77
Human papillomavirus type 16 DNA in periungual squamous cell carcinomas. JAMA (1989) 1.65
Introduction of a viral thymidine kinase gene and the human beta-globin gene into developmentally multipotential mouse teratocarcinoma cells. Proc Natl Acad Sci U S A (1980) 1.58
Analysis of the herpes simplex virus type 1 promoter controlling the expression of UL38, a true late gene involved in capsid assembly. J Virol (1991) 1.54
PhenoDB: an integrated client/server database for linkage and population genetics. Comput Biomed Res (1996) 1.54
Dissection of immediate-early gene promoters from herpes simplex virus: sequences that respond to the virus transcriptional activators. J Virol (1987) 1.53
Relationship of human papillomavirus type to grade of cervical intraepithelial neoplasia. JAMA (1992) 1.51
A polymerase chain reaction-enzyme-linked immunosorbent assay method for detecting human papillomavirus in cervical carcinomas and high-grade cervical cancer precursors. Obstet Gynecol (1995) 1.50
In situ hybridization analysis of HPV 16 DNA sequences in early cervical neoplasia. Am J Pathol (1986) 1.48
Differentiation of Nocardia from rapidly growing Mycobacterium species by PCR-RFLP analysis. Diagn Microbiol Infect Dis (1994) 1.45
Alterations in the protein synthetic apparatus of Friend erythroleukemia cells infected with vesicular stomatitis virus or herpes simplex virus. J Virol (1978) 1.45
Bonded amalgam sealants: two-year clinical results. J Am Dent Assoc (1998) 1.39
Varicella vaccine: the American experience. J Infect Dis (1992) 1.35
Molecular analysis of chromosome-mediated gene transfer. Proc Natl Acad Sci U S A (1979) 1.31
Mutational analysis of the sequence encoding ICP0 from herpes simplex virus type 1. Virology (1991) 1.31
Typing of human papillomaviruses by polymerase chain reaction amplification with L1 consensus primers and RFLP analysis. Mol Cell Probes (1992) 1.29
Allograft versus autograft anterior cruciate ligament reconstruction: 3- to 5-year outcome. Clin Orthop Relat Res (1996) 1.27
Phenotypic switching in cells transformed with the herpes simplex virus thymidine kinase gene. Mol Cell Biol (1982) 1.18
Alterations in the protein synthetic apparatus of cells infected with herpes simplex virus. Virology (1979) 1.16
Enrollment in and compliance with a community demonstration program of caries prevention for grades kindergarten through 12. J Public Health Dent (1982) 1.12
Control of expression of the herpes simplex virus thymidine kinase gene in biochemically transformed cells. J Gen Virol (1984) 1.11
Multimerization of ICP0, a herpes simplex virus immediate-early protein. J Virol (1992) 1.10
Barriers to computerized prescribing. JAMA (1998) 1.09
Isolation and characterization of a functional cDNA encoding ICP0 from herpes simplex virus type 1. J Virol (1991) 1.06
Two overlapping transcription units which extend across the L-S junction of herpes simplex virus type 1. J Virol (1995) 1.05
Replication and recombination in adenovirus-infected cells are temporally and functionally related. J Virol (1984) 1.05
Adenovirus vector expressing functional herpes simplex virus ICP0. J Virol (1988) 1.04
Interaction of zyxin, a focal adhesion protein, with the e6 protein from human papillomavirus type 6 results in its nuclear translocation. J Virol (2001) 1.01
Inhibition by vesicular stomatitis virus of herpes simplex virus-directed protein synthesis. Virology (1983) 0.97
Transduction of the Chinese hamster ovary aprt gene by herpes simplex virus. J Virol (1984) 0.96
Utilization of deoxyribonucleoside triphosphates in the cellular synthesis of DNA by Bacillus subtilis. Biochem Biophys Res Commun (1971) 0.92
Repression of the alpha0 gene by ICP4 during a productive herpes simplex virus infection. J Virol (1996) 0.92
Mental health consultation to a preschool following the murder of a mother and child. Hosp Community Psychiatry (1985) 0.91
Familial café au lait spots: a variant of neurofibromatosis type 1. J Med Genet (1995) 0.91
A (R80Q) mutation in 17 beta-hydroxysteroid dehydrogenase type 3 gene among Arabs of Israel is associated with pseudohermaphroditism in males and normal asymptomatic females. J Clin Endocrinol Metab (1996) 0.89
Papillomavirus infection of the uterine cervix. Microb Pathog (1987) 0.89
Evidence of latent varicella-zoster virus in rat dorsal root ganglia. J Infect Dis (1998) 0.88
Transactivation by herpes simplex virus proteins ICP4 and ICP0 in vaccinia virus infected cells. Virology (1991) 0.87
Enhancer-facilitated expression of prokaryotic and eukaryotic genes using human histone gene 5' regulatory sequences. Biochem Cell Biol (1986) 0.87
Placental mesenchymal dysplasia associated with transient neonatal diabetes mellitus and paternal UPD6. Placenta (2008) 0.82
Leprosy research in the post-genome era. Lepr Rev (2001) 0.82
Biologic properties and nucleotide sequence analysis of human papillomavirus type 51. J Virol (1991) 0.82
Transformation of mammalian cells with genes from prokaryotes and eukaryotes. 1979. Biotechnology (1992) 0.82
Live attenuated varicella vaccine for prevention of herpes zoster. Biologicals (1997) 0.81
Differential stability of alpha- and beta-globin mRNAs after infection with herpes simplex virus. FEBS Lett (1978) 0.79
Congenital varicella-zoster virus infection and Barrett's esophagus. J Infect Dis (1998) 0.79
Retraction: renaturation of denatured lambda repressor requires heat shock proteins. Cell (1992) 0.78
Increased severity over generations of Charcot-Marie-Tooth disease type 1A. J Neurol (2008) 0.78
Identification of sequences coding for thymidine kinase in herpes simplex virus and transformed cell DNA. IARC Sci Publ (1978) 0.77
Epidermoid carcinoma subsequent to a gunshot wound of the face. J Natl Med Assoc (1984) 0.77
Effects of stress-relevant and -irrelevant filmed modeling on children's responses to dental treatment. J Pediatr Psychol (1985) 0.75
Academic and legal aspects of authorship disputes. JAMA (1999) 0.75
Curriculum design issues through the eyes of the trainer. Gerontol Geriatr Educ (1981) 0.75
A PCR strategy that differentiates two alleles for a single base insertion within a T repeat. Biotechniques (1993) 0.75
Chromosomal DNA homologous to Herpes simplex virus 1 in a mouse L-cell line. Cytogenet Cell Genet (1981) 0.75
The community caries prevention demonstration program: fluoride mouthrinses for grades K-12. CDA J (1982) 0.75
The structure and function of a eukaryotic promoter. Princess Takamatsu Symp (1982) 0.75
Medical Informatics Training at Yale University School of Medicine. Yearb Med Inform (1996) 0.75
Transcriptional control of transformed genes. Oncodev Biol Med (1982) 0.75
Alterations in the protein synthetic apparatus of Friend erythroleukemia cells during their erythroid differentiation. J Cell Physiol (1978) 0.75